Company | Name | Exchange | Sector | Industry | 3 Month | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Metaplanet | OTC Markets | 377.8% | $6.96B | 301x | 3.85 | $10.82 | -1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
ABVC Biopharma | NASDAQ | Healthcare | Biotechnology & Medical Research | 274.7% | $50.54M | -7.9x | -0.2 | $3.99 | 28.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
IREN Ltd | NASDAQ | Technology | Financial Technology (Fintech) & Infrastructure | 186.1% | $4.07B | -45.5x | 1.92 | $16.96 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 21.1% Upside | Upgrade to Pro+ | |
Robinhood Markets | NASDAQ | Technology | Financial Technology (Fintech) & Infrastructure | 166.6% | $82.52B | 51.7x | 0.05 | $93.48 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -22.9% Downside | Upgrade to Pro+ | |
Nuscale Power | NYSE | Utilities | Electrical Utilities & IPPs | 154.5% | $10.20B | -17x | 0.7 | $36.70 | 2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -2.5% Downside | Upgrade to Pro+ | |
D Wave Quantum | NYSE | Technology | Software & IT Services | 154.4% | $5.30B | -28x | 2.63 | $16.76 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 7.2% Upside | Upgrade to Pro+ | |
Argo Corp | OTC Markets | Technology | Software & IT Services | 142.3% | $58.88M | -0.06 | $0.41 | -2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Coinbase Global | NASDAQ | Technology | Financial Technology (Fintech) & Infrastructure | 126.2% | $90.78B | 60.6x | 12.08 | $357.10 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -21% Downside | Upgrade to Pro+ | |
Ast Spacemobile | NASDAQ | Technology | Telecommunications Services | 113.8% | $15.48B | -25.2x | 0.4 | $45.69 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -3.5% Downside | Upgrade to Pro+ | |
Critical Metals Corp | NASDAQ | Basic Materials | Metals & Mining | 113.5% | $360.54M | -1x | $3.22 | -7.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Septerna | NASDAQ | Healthcare | Biotechnology & Medical Research | 111.3% | $483.46M | -2.8x | 0.06 | $10.85 | -4.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Ascentage Pharma | NASDAQ | Healthcare | Biotechnology & Medical Research | 110% | $3.70B | -30.1x | -1.11 | $42.04 | -1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -34.7% Downside | Upgrade to Pro+ | |
CureVac NV | NASDAQ | Healthcare | Biotechnology & Medical Research | 105.7% | $1.22B | 5.8x | 0.03 | $5.41 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -20.3% Downside | Upgrade to Pro+ | |
Stoke Therapeutics | NASDAQ | Healthcare | Biotechnology & Medical Research | 91% | $636.60M | 13.4x | 0.09 | $11.69 | 1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
ProQR Therapeutics NV | NASDAQ | Healthcare | Biotechnology & Medical Research | 86.3% | $224.49M | -5.5x | 3.76 | $2.14 | -1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Gold Reserve Inc | OTC Markets | Industrials | Professional & Commercial Services | 83.4% | $395.46M | -17.2x | -1.44 | $3.49 | 8.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Phathom Pharma | NASDAQ | Healthcare | Pharmaceuticals | 83.2% | $598.98M | -1.6x | 0.11 | $8.67 | -2.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Gold Royalty | NYSE | Financial | Investment Banking & Investment Services | 75.6% | $406.61M | -119.5x | -1.36 | $2.38 | 3.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 26.1% Upside | Upgrade to Pro+ | |
Hims Hers Health | NYSE | Healthcare | Healthcare Providers & Services | 72.8% | $10.82B | 63.3x | 0.01 | $48.42 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -8.3% Downside | Upgrade to Pro+ | |
DeFi Tech | NASDAQ | Technology | Financial Technology (Fintech) & Infrastructure | 70.7% | $969.66M | 55.8x | 0.34 | $2.81 | -10.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
NYSE | Technology | Software & IT Services | 68.8% | $28.98B | 232x | 2.32 | $153.42 | -2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -4.5% Downside | Upgrade to Pro+ | ||
Astera Labs | NASDAQ | Technology | Semiconductors & Semiconductor Equipment | 64.6% | $14.97B | 280x | 3.28 | $89.62 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 10.1% Upside | Upgrade to Pro+ | |
Arrowhead Pharma | NASDAQ | Healthcare | Biotechnology & Medical Research | 63.8% | $2.31B | -14.7x | -0.22 | $16.85 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Kuros Biosciences | OTC Markets | Healthcare | Biotechnology & Medical Research | 61.1% | $1.38B | -286.4x | -4.19 | $35.80 | 5.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Blueprint Medicines Corp | NASDAQ | Healthcare | Biotechnology & Medical Research | 60% | $8.31B | -52.3x | -1.11 | $128.40 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 0.5% Upside | Upgrade to Pro+ | |
Biostem Tech | OTC Markets | Healthcare | Pharmaceuticals | 55.9% | $199.83M | 9.6x | 0 | $12 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Futu | NASDAQ | Technology | Financial Technology (Fintech) & Infrastructure | 54% | $17.16B | 20.4x | 0.35 | $123.13 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 18.9% Upside | Upgrade to Pro+ | |
Sailfish Royalty | OTC Markets | Basic Materials | Metals & Mining | 53.3% | $129.71M | 174.1x | 0.89 | $1.74 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Abivax ADR | NASDAQ | Healthcare | Biotechnology & Medical Research | 52.2% | $525.59M | -0.22 | $7.95 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Dominari Holdings | NASDAQ | Financial | Investment Banking & Investment Services | 48% | $74.17M | -0.9x | 0.08 | $5.10 | -3.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Volitionrx Ltd | NYSE | Healthcare | Biotechnology & Medical Research | 48% | $70.88M | -2.6x | -0.08 | $0.67 | -9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Regenxbio Inc | NASDAQ | Healthcare | Biotechnology & Medical Research | 47.4% | $423.77M | -2.7x | -0.06 | $8.43 | -3.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
51Talk Online Education DRC | NYSE | Academic & Educational Services | Miscellaneous Educational Service Providers | 46.9% | $160.96M | -37x | -0.48 | $31 | 12.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Elron Electronic Industries | OTC Markets | Financial | Investment Banking & Investment Services | 40.7% | $81.20M | 4.1x | 0.01 | $1.54 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
XOMA | NASDAQ | Consumer Cyclicals | Media & Publishing | 40.2% | $314.25M | -36.7x | -0.46 | $26.17 | -2.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Financial 15 | OTC Markets | Financial | Collective Investments | 39.9% | $437.67M | 1.6x | $7.12 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Yuanbao | NASDAQ | 39.2% | $1B | 6.5x | 0.04 | $23 | 3.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Dividend 15 Split | OTC Markets | Financial | Investment Banking & Investment Services | 37.7% | $606.58M | 1.9x | $4.59 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Cellectis | NASDAQ | Healthcare | Biotechnology & Medical Research | 36.2% | $115.38M | -2.6x | -0.04 | $1.60 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
China Fund | NYSE | Financial | Collective Investments | 35.4% | $146.86M | 7.6x | $14.70 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Calamos Global Total Return Closed | NASDAQ | Financial | Collective Investments | 35.2% | $114.49M | 13.9x | $11.62 | -1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Keros | NASDAQ | Healthcare | Biotechnology & Medical Research | 34.8% | $544.25M | 122.6x | 1.27 | $13.40 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Ares Commercial RE | NYSE | Real Estate | Residential & Commercial REITs | 34.1% | $258.43M | -19.7x | -0.29 | $4.70 | -4.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 1.2% Upside | Upgrade to Pro+ | |
Avadel Pharma | NASDAQ | Healthcare | Pharmaceuticals | 33.5% | $865.32M | -34.3x | -0.39 | $8.89 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Up Fintech | NASDAQ | Financial | Investment Banking & Investment Services | 33% | $1.60B | 19x | 0.22 | $9.12 | -2.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 21.5% Upside | Upgrade to Pro+ | |
Better Home Finance Holding | NASDAQ | Financial | Banking Services | 30.9% | $202.07M | -1x | -0.01 | $13.38 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Capital Product | NASDAQ | Industrials | Freight & Logistics Services | 29.5% | $1.36B | 39.6x | 0.94 | $23.29 | -1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 1.5% Upside | Upgrade to Pro+ | |
Vista Oil Gas | NYSE | Energy | Oil & Gas | 29.3% | $4.95B | 9.3x | 0.31 | $46.84 | -2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 44.8% Upside | Upgrade to Pro+ | |
Himalaya Shipping | NYSE | Industrials | Freight & Logistics Services | 29.3% | $284.45M | 20.1x | 0.13 | $6.33 | 2.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 42.4% Upside | Upgrade to Pro+ | |
ARS Pharmaceuticals | NASDAQ | Healthcare | Biotechnology & Medical Research | 28.8% | $1.68B | -108.8x | -1.5 | $17.08 | 3.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |